Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Dong-E-E-Jiao Co.,Ltd.
  6. Summary
    000423   CNE0000006Y9

DONG-E-E-JIAO CO.,LTD.

(000423)
  Report
End-of-day quote Shenzhen Stock Exchange  -  2022-06-30
36.35 CNY   -1.62%
04/28Dong-E-E-Jiao's Profit, Revenue Rise in Q1; Shares Jump 5%
MT
04/28Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/18Dong-E-E-Jiao Co.,Ltd. Provides Earnings Guidance for the Three Months Ended 31 March 2022
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
06/27/2022 06/28/2022 06/29/2022 06/30/2022 07/01/2022 Date
37 36.61 36.58 36.95 36.35 Last
9725579 4210776 5610894 6726230 4091177 Volume
+2.49% -1.05% -0.08% +1.01% -1.62% Change
Estimated financial data (e)
Sales 2022 4 472 M 667 M 667 M
Net income 2022 932 M 139 M 139 M
Net cash position 2022 4 232 M 632 M 632 M
P/E ratio 2022 26,1x
Yield 2022 2,26%
Sales 2023 5 370 M 801 M 801 M
Net income 2023 1 215 M 181 M 181 M
Net cash position 2023 4 201 M 627 M 627 M
P/E ratio 2023 21,3x
Yield 2023 2,06%
Capitalization 23 409 M 3 493 M 3 493 M
EV / Sales 2022 4,29x
EV / Sales 2023 3,58x
Nbr of Employees 4 180
Free-Float 65,8%
More Financials
Company
Dong-E-E-Jiao Co., Ltd. specializes in the manufacturing and marketing of Chinese traditional medicines and health products. The products are primarily for deficiencies in the blood, immunodeficiency, indigestion, insomnia and fatigue. 
Read more
Sector
Pharmaceuticals
Calendar
08/17Earnings Release
More about the company
Ratings of Dong-E-E-Jiao Co.,Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about DONG-E-E-JIAO CO.,LTD.
04/28Dong-E-E-Jiao's Profit, Revenue Rise in Q1; Shares Jump 5%
MT
04/28Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2..
CI
04/18Dong-E-E-Jiao Co.,Ltd. Provides Earnings Guidance for the Three Months Ended 31 March 2..
CI
03/29UBS Adjusts Dong-E-E-Jiao's Price Target to 39.3 Yuan From 37.5 Yuan, Keeps at Neutral
MT
03/27Dong-E-E-Jiao Co.,Ltd. Proposes Cash Dividend as of 31 December 2021
CI
03/25Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 20..
CI
01/27Dong-E-E-Jiao Expects Higher Profit in 2021
MT
01/27Dong-E-E-Jiao Co.,Ltd. Provides Earnings Guidance for the Year Ended December 31, 2021
CI
2021Dong-E-E-Jiao Swings to Profit in January-September
MT
2021Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30,..
CI
2021DONG E E JIAO : Forecasts Up to 164% Surge in Q3 Profit
MT
2021Dong-E-E-Jiao Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
2021Dong-E-E-Jiao Co.,Ltd. Announces Cash Dividend for the Year 2020, Payable on August 20,..
CI
2021Dong-E-E-Jiao Co.,Ltd. Announces Management Elections
CI
2021Dong-E-E-Jiao Co.,Ltd. Approves 2020 Profit Distribution Plan At the Annual General Mee..
CI
More news
News in other languages on DONG-E-E-JIAO CO.,LTD.
04/28Le bénéfice et le chiffre d'affaires de Dong-E-E-Jiao augmentent au premier trimestre ;..
04/28Dong-E-E-Jiao Co.,Ltd. annonce ses résultats pour le premier trimestre se terminant le ..
04/18Dong-E-E-Jiao Co.,Ltd. fournit des prévisions de bénéfices pour les trois mois se termi..
03/27Dong-E-E-Jiao Co.,Ltd. propose un dividende en espèces à compter du 31 décembre 2021
03/25Dong-E-E-Jiao Co.,Ltd. annonce ses résultats pour l'année complète se terminant le 31 d..
More news
Analyst Recommendations on DONG-E-E-JIAO CO.,LTD.
More recommendations
Chart DONG-E-E-JIAO CO.,LTD.
Duration : Period :
Dong-E-E-Jiao Co.,Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DONG-E-E-JIAO CO.,LTD.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Last Close Price 36,35 CNY
Average target price 40,21 CNY
Spread / Average Target 10,6%
EPS Revisions
Managers and Directors
Jie Cheng President & Director
Rong Deng Chief Financial Officer, Secretary, Director & VP
Ran Tao Chairman-Supervisory Board
Deng Feng Gao Chairman
Yuan Xing Zhang Independent Director
Sector and Competitors
1st jan.Capi. (M$)
DONG-E-E-JIAO CO.,LTD.-25.44%3 552
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.21.94%6 060
TASLY PHARMACEUTICAL GROUP CO., LTD-33.94%2 331
PT INDUSTRI JAMU DAN FARMASI SIDO MUNCUL TBK14.45%2 009
GUIZHOU XINBANG PHARMACEUTICAL CO., LTD.-2.70%2 005
CANOPY GROWTH CORPORATION-66.85%1 145